Navigation Links
Seno Medical Instruments to Present Updated Data from Pivotal European Study at 2016 San Antonio Breast Cancer Symposium

SAN ANTONIO, Dec. 5, 2016 /PRNewswire/ -- Seno Medical Instruments, Inc., the company pioneering the development of opto-acoustic technology as a new tool to improve the process of diagnosing breast cancer, today announced that it will present data from its European MAESTRO post-market surveillance and clinical follow-up study at the 2016 San Antonio Breast Cancer Symposium (SABCS) taking place from December 6-10, 2016 at the Henry B. Gonzalez Convention Center in San Antonio, Texas.

Seno Medical Instruments will present two poster presentations on Friday, December 9:

  • Breast Biopsy Histology Relationships with Opto-Acoustic Imaging of Breast Masses, Poster Session 4, 7:30 a.m. – 9:00 a.m. CST, Hall 1
  • Opto-Acoustic Imaging of the Breast: Downclassification and Upclassification of Suspicious Breast Masses, Poster Session 4, 7:30 a.m. – 9:00 a.m. CST, Hall 1

Thomas Stavros, MD, FACR, FSRU, FRANZCR, Medical Director of Seno Medical Instruments, will present the histological analysis on behalf of Marc van de Vijver, MD, PhD, Department of Pathology at the Netherlands Cancer Institute, Amsterdam, while the MAESTRO study's principal investigator, Ruud Pijnappel, MD, PhD, Radiologist, University Medical Center, Utrecht, NL, will present the opto-acoustic imaging downclassification and upclassifciation data.

"The Imagio® breast imaging system represents a significant advance to improve the diagnoses of breast cancer by helping to determine the appropriate classification of breast masses," said Thomas Stavros, MD and Medical Director of SENO Medical. "The presentation of the histological data will be of particular interest to the oncology community as it will identify a correlation between the opto-acoustic imaging findings and histologic grade of the breast masses."

"We believe the new data from the MAESTRO study will provide additional clinical evidence to validate our Imagio opto-acoustic breast imaging system and allow radiologists to make more precise and accurate diagnoses when assessing suspicious breast masses in patients," said Tom Umbel, CEO of Seno Medical Instruments.

Seno Medical Instruments expects to announce the final results from the MAESTRO study in early 2017. Results from the PIONEER study – the company's U.S. trial of more than 2,000 patients -- are expected to be announced in the second half of 2017.

About Seno Medical Instruments, Inc.

Seno Medical Instruments, Inc. is a San Antonio, Texas-based medical imaging company committed to the development and commercialization of a new modality in cancer diagnosis: opto-acoustic imaging. Seno's Imagio breast imaging system fuses opto-acoustic technology with ultrasound to generate functional and anatomical images of the breast. The opto-acoustic images provide a unique color map in and around suspicious breast masses while the ultrasound provides a traditional anatomic image. Through the appearance or absence of the two hallmark indicators of cancer – angiogenesis and deoxygenation – Seno believes that Imagio images will be a more effective tool to help radiologists confirm or rule out malignancy than current diagnostic imaging modalities – without exposing patients to potentially harmful ionizing radiation (x-rays) or contrast agents. Seno's platform technology may also address other disease applications in organs other than the breast, as well as assessing other breast problems, such as early response to neoadjuvant chemotherapy or hormonal treatments of breast cancer. To learn more about Seno's opto-acoustic imaging technology and applications, visit

About the San Antonio Breast Cancer Symposium

The San Antonio Breast Cancer Symposium is an international symposium directed primarily towards academic and private physicians and researchers involved in breast cancer in medical, surgical, gynecologic, and radiation oncology, as well as other appropriate health care professionals. Approximately 7,500 attendees from more than 90 countries are expected to attend.

About Breast Cancer

According to the American Cancer Society, an estimated 246,660 new cases of invasive breast cancer, along with 61,000 new cases of non-invasive (in situ) breast cancer, will be diagnosed in U.S. women in 2016. Additionally, there are over 1.6 million biopsies performed annually and recent reported data noted an 81% "false positive" rate of biopsy procedures – the portion of biopsies that do not lead to breast cancer surgery. An estimated 40,450 women in the U.S. are expected to die in 2016 from breast cancer. Only lung cancer accounts for more cancer deaths in women.

Media Contact

Erich Sandoval
Lazar Partners Ltd.
Tel: +1 213-908-6226

1 J Womens Health, September 2014, Vol. 23:S1,
2 An Actuarial Analysis of Breast Cancer Screening and Follow-on Diagnostics in a Commercially Insured
3 Population.(2014).Millman, Inc., NY.
4 U.S. Breast Cancer Statistics | (2016).

To view the original version on PR Newswire, visit:

SOURCE Seno Medical Instruments, Inc.
Copyright©2016 PR Newswire.
All rights reserved

Related medicine technology :

1. Vasomedical Announces Financial Results for the First Quarter of 2013
2. CCS Medical Moves Forward as Medicare Winner
3. PENTAX Medical Launches Industrys Highest* Resolution HD+ Imaging Technology For Flexible Endoscopy
4. SOAPware President Randall Oates, M.D. Among First NCQA Certified Patient-Centered Medical Home Content Experts
5. RAD Technology Medical Systems Delivers Innovative Time Saving Modular Construction At New Swedish Cancer Institute Facility
6. PENTAX Medical And Hitachi-Aloka Medical Continue Joint Innovation And Global Leadership In Endoscopic Ultrasound Systems
7. ACLS Online Course Manuals are Now Available at No Cost through United Medical Education
8. Statistical Challenges in Medical Device Trail Evaluation
9. Claret Medical, Inc. Announces Publication of the First Clinical Research on the Frequency and Composition of Embolic Debris Captured during TAVR
10. Neuralstem ALS Trial Principal Investigator, Dr. Eva Feldman, Presented Phase I Data At The Neuro Diabetes Medical Symposium In Romania
11. Sequent Medical, Inc. bringt neue SL-Produktfamilie seiner WEB Geräte zur Embolisation von Aneurysmen auf den Markt
Post Your Comments:
(Date:3/30/2021)... ... March 29, 2021 , ... The University of Texas Health Science Center ... San Antonio Multispecialty and Research Hospital, a destination center for research and treatment of ... In a nod to the COVID-19 pandemic, the ceremony was held virtually. , William ...
(Date:3/30/2021)... ... March 29, 2021 , ... Iora Health ... primary care, has partnered with Devoted Health , one of the fastest-growing ... across Maricopa County and provides seniors with the highest-quality care and experience possible, ...
(Date:3/30/2021)... CITY (PRWEB) , ... March 29, 2021 , ... ... has joined the Vaccine Credential Initiative (VCI), a group bringing together leading health ... record of vaccination status, based on open, interoperable standards. By joining the VCI ...
Breaking Medicine Technology:
(Date:3/30/2021)... , ... March 29, 2021 , ... ... the 21st Century , A Virtual Workshop Presented by WCG FDAnews and Cerulean ... 4:30 pm EDT, , Are one’s SOPs written for the ...
(Date:3/30/2021)... ... March 29, 2021 , ... According to data released ... reproductive age (13-44) in need of publicly funded contraception live in counties impacted by ... Colorado’s 64 counties have lost some of their Title X resources. , The ...
(Date:3/30/2021)... ... March 29, 2021 , ... Health Literacy Innovations (HLI), a ... confusion due to low health literacy today announces a new partnership with the ... work with ACAP’s member Safety Net Health Plans, those that provide comprehensive health ...
(Date:3/30/2021)... ... ... Dr. Colin Campbell is proud to announce the 1 year anniversary in their new state ... internal medicine and is a primary care specialist who has been practicing for 23 years. ... keep South Jersey healthy one patient at a time. , “Over the past year, Dr. ...
(Date:3/30/2021)... ... March 30, 2021 , ... The COVID-19 ... and survivors; their families; and their caregivers. Crossroads4Hope is addressing the needs of ... emotional support system, MyGo2Support, which meets needs of people impacted by cancer, no ...
Breaking Medicine News(10 mins):